Literature DB >> 9403451

Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects.

M E Jensen1, A J Evans, J M Mathis, D F Kallmes, H J Cloft, J E Dion.   

Abstract

PURPOSE: To describe a technique for percutaneous vertebroplasty of osteoporotic vertebral body compression fractures and to report early results of its use.
METHODS: The technique was used over a 3-year period in 29 patients with 47 painful vertebral fractures. The technique involves percutaneous puncture of the involved vertebra(e) via a transpedicular approach followed by injection of polymethylmethacrylate (PMMA) into the vertebral body.
RESULTS: The procedure was technically successful in all patients, with an average injection amount of 7.1 mL PMMA per vertebral body. Two patients sustained single, nondisplaced rib fractures during the procedure; otherwise, no clinically significant complications were noted. Twenty-six patients (90%) reported significant pain relief immediately after treatment.
CONCLUSION: Vertebroplasty is a valuable tool in the treatment of painful osteoporotic vertebral fractures, providing acute pain relief and early mobilization in appropriate patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403451      PMCID: PMC8337380     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  224 in total

Review 1.  Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures.

Authors:  J M Mathis; J D Barr; S M Belkoff; M S Barr; M E Jensen; H Deramond
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Percutaneous vertebroplasty: a special syringe for cement injection.

Authors:  I Al-Assir; A Perez-Higueras; J Florensa; A Muñoz; E Cuesta
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

3.  Intraosseous venography during percutaneous vertebroplasty: is it needed?

Authors:  Huy M Do
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

4.  Paradoxical cerebral arterial embolization of cement during intraoperative vertebroplasty: case report.

Authors:  Rebecca Scroop; Joseph Eskridge; Gavin W Britz
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  Ex vivo biomechanical comparison of hydroxyapatite and polymethylmethacrylate cements for use with vertebroplasty.

Authors:  Stephen M Belkoff; John M Mathis; Louis E Jasper
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

6.  Vertebroplasty Using Calcium Triglyceride Bone Cement (Kryptonite™) for Vertebral Compression Fractures. A Single-Centre Preliminary Study of Outcomes at One-Year Follow-up.

Authors:  Gianluigi Guarnieri; Mario Tecame; Roberto Izzo; Pasquale Vassallo; Angela Sardaro; Francesca Iasiello; Carlo Cavaliere; Mario Muto
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

7.  Retrospective review of procedural parameters and outcomes of percutaneous vertebroplasty in 673 patients.

Authors:  Benny S Kim; Barbara Hum; Jung Cheol Park; In Sup Choi
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

8.  Percutaneous vertebroplasty in vertebral compression fractures of benign or malignant origin: a prospective study of 1188 patients with follow-up of 12 months.

Authors:  Anastasios Mpotsaris; Razmin Abdolvahabi; Bastian Hoffleith; Janpeter Nickel; Ali Harati; Christian Loehr; Chun Hee Gerdes; Svenja Hennigs; Werner Weber
Journal:  Dtsch Arztebl Int       Date:  2011-05-13       Impact factor: 5.594

Review 9.  [Percutaneous vertebroplasty (pv): indications, contraindications, and technique].

Authors:  R T Hoffmann; T F Jakobs; A Wallnöfer; M F Reiser; T K Helmberger
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

10.  Vertebroplasty in the mid- and upper thoracic spine.

Authors:  David F Kallmes; Patricia A Schweickert; William F Marx; Mary E Jensen
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.